134 related articles for article (PubMed ID: 35305716)
1. In silico tools and databases for designing cancer immunotherapy.
Dhall A; Jain S; Sharma N; Naorem LD; Kaur D; Patiyal S; Raghava GPS
Adv Protein Chem Struct Biol; 2022; 129():1-50. PubMed ID: 35305716
[TBL] [Abstract][Full Text] [Related]
2. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
[TBL] [Abstract][Full Text] [Related]
3. A Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer.
Gupta S; Chaudhary K; Dhanda SK; Kumar R; Kumar S; Sehgal M; Nagpal G; Raghava GP
PLoS One; 2016; 11(11):e0166372. PubMed ID: 27832200
[TBL] [Abstract][Full Text] [Related]
4. GeNeo: A Bioinformatics Toolbox for Genomics-Guided Neoepitope Prediction.
Al Seesi S; Al-Okaily A; Shcheglova TV; Sherafat E; Alqahtani FH; Hagymasi AT; Kaur A; Srivastava PK; Măndoiu II
J Comput Biol; 2023 Apr; 30(4):538-551. PubMed ID: 36999902
[TBL] [Abstract][Full Text] [Related]
5. HLAncPred: a method for predicting promiscuous non-classical HLA binding sites.
Dhall A; Patiyal S; Raghava GPS
Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35580839
[TBL] [Abstract][Full Text] [Related]
6. Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics.
Dhanda SK; Usmani SS; Agrawal P; Nagpal G; Gautam A; Raghava GPS
Brief Bioinform; 2017 May; 18(3):467-478. PubMed ID: 27016393
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics for Cancer Immunotherapy.
Holtsträter C; Schrörs B; Bukur T; Löwer M
Methods Mol Biol; 2020; 2120():1-9. PubMed ID: 32124308
[TBL] [Abstract][Full Text] [Related]
8. In Silico Tool for Identification, Designing, and Searching of IL13-Inducing Peptides in Antigens.
Jain S; Dhall A; Patiyal S; Raghava GPS
Methods Mol Biol; 2023; 2673():329-338. PubMed ID: 37258925
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment of cancer patients based on HLA-I alleles, neobinders and expression of cytokines.
Dhall A; Patiyal S; Kaur H; Raghava GPS
Comput Biol Med; 2023 Dec; 167():107594. PubMed ID: 37918263
[TBL] [Abstract][Full Text] [Related]
10. Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy.
Richard G; Princiotta MF; Bridon D; Martin WD; Steinberg GD; De Groot AS
Expert Rev Vaccines; 2022 Feb; 21(2):173-184. PubMed ID: 34882038
[TBL] [Abstract][Full Text] [Related]
11. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery.
de Sousa E; Lérias JR; Beltran A; Paraschoudi G; Condeço C; Kamiki J; António PA; Figueiredo N; Carvalho C; Castillo-Martin M; Wang Z; Ligeiro D; Rao M; Maeurer M
Front Immunol; 2021; 12():592031. PubMed ID: 34335558
[TBL] [Abstract][Full Text] [Related]
12. In-silico identification of subunit vaccine candidates against lung cancer-associated oncogenic viruses.
Lathwal A; Kumar R; Raghava GPS
Comput Biol Med; 2021 Mar; 130():104215. PubMed ID: 33465550
[TBL] [Abstract][Full Text] [Related]
13. NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy.
Xia J; Bai P; Fan W; Li Q; Li Y; Wang D; Yin L; Zhou Y
Front Immunol; 2021; 12():644637. PubMed ID: 33927717
[TBL] [Abstract][Full Text] [Related]
14. Genome-based solutions for managing mucormycosis.
Tomer R; Patiyal S; Kaur D; Choudhury S; Raghava GPS
Adv Protein Chem Struct Biol; 2024; 139():383-403. PubMed ID: 38448141
[TBL] [Abstract][Full Text] [Related]
15. In Silico Design of Chemically Modified Cell-Penetrating Peptides.
Kumar V; Raghava GPS
Methods Mol Biol; 2022; 2383():63-71. PubMed ID: 34766282
[TBL] [Abstract][Full Text] [Related]
16. Computational Methods for Identification of T Cell Neoepitopes in Tumors.
Jurtz VI; Olsen LR
Methods Mol Biol; 2019; 1878():157-172. PubMed ID: 30378075
[TBL] [Abstract][Full Text] [Related]
17. A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.
Toor JS; Rao AA; McShan AC; Yarmarkovich M; Nerli S; Yamaguchi K; Madejska AA; Nguyen S; Tripathi S; Maris JM; Salama SR; Haussler D; Sgourakis NG
Front Immunol; 2018; 9():99. PubMed ID: 29441070
[TBL] [Abstract][Full Text] [Related]
18. A Web-Based Method for the Identification of IL6-Based Immunotoxicity in Vaccine Candidates.
Dhall A; Patiyal S; Sharma N; Usmani SS; Raghava GPS
Methods Mol Biol; 2023; 2673():317-327. PubMed ID: 37258924
[TBL] [Abstract][Full Text] [Related]
19. Advances in personalized neoantigen vaccines for cancer immunotherapy.
Sun C; Xu S
Biosci Trends; 2020 Nov; 14(5):349-353. PubMed ID: 32908077
[TBL] [Abstract][Full Text] [Related]
20. Cancer immunotherapy targeting neoantigens.
Lu YC; Robbins PF
Semin Immunol; 2016 Feb; 28(1):22-7. PubMed ID: 26653770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
